Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2414261
Max Phase: Preclinical
Molecular Formula: C25H27Cl2N7
Molecular Weight: 496.45
Molecule Type: Small molecule
Associated Items:
ID: ALA2414261
Max Phase: Preclinical
Molecular Formula: C25H27Cl2N7
Molecular Weight: 496.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)n1nnnc1C(c1ccc(Cl)cc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1
Standard InChI: InChI=1S/C25H27Cl2N7/c1-25(2,3)34-24(29-30-31-34)23(17-4-6-18(26)7-5-17)33-14-12-32(13-15-33)22-10-11-28-21-16-19(27)8-9-20(21)22/h4-11,16,23H,12-15H2,1-3H3
Standard InChI Key: BNJZINVVRMJCLH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 496.45 | Molecular Weight (Monoisotopic): 495.1705 | AlogP: 5.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.97 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 7.18 | CX LogP: 5.46 | CX LogD: 5.27 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.39 | Np Likeness Score: -1.81 |
1. Pandey S, Agarwal P, Srivastava K, Rajakumar S, Puri SK, Verma P, Saxena JK, Sharma A, Lal J, Chauhan PM.. (2013) Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents., 66 [PMID:23792317] [10.1016/j.ejmech.2013.05.023] |
Source(1):